Allan C. deCamp

9.1k total citations · 1 hit paper
20 papers, 1.4k citations indexed

About

Allan C. deCamp is a scholar working on Virology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Allan C. deCamp has authored 20 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Virology, 8 papers in Infectious Diseases and 8 papers in Molecular Biology. Recurrent topics in Allan C. deCamp's work include HIV Research and Treatment (17 papers), vaccines and immunoinformatics approaches (7 papers) and Immune Cell Function and Interaction (7 papers). Allan C. deCamp is often cited by papers focused on HIV Research and Treatment (17 papers), vaccines and immunoinformatics approaches (7 papers) and Immune Cell Function and Interaction (7 papers). Allan C. deCamp collaborates with scholars based in United States, South Africa and Belgium. Allan C. deCamp's co-authors include John W. Heitman, Andrea Stacey, Philip J. Norris, Qin Li, Elizabeth Taylor, Dongfeng Li, Douglas I. Grove, Mila Lebedeva, Persephone Borrow and Steven G. Self and has published in prestigious journals such as Journal of Clinical Investigation, Bioinformatics and The Journal of Immunology.

In The Last Decade

Allan C. deCamp

20 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Induction of a Striking Systemic Cytokine Cascade prior to Peak Viremia in Acute Human Immunodeficiency Virus Type 1 Infection, in Contrast to More Modest and Delayed Responses in Acute Hepatitis B and C Virus Infections

2009 555 citations Andrea Stacey, Philip J. Norris et al. Journal of Virology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Allan C. deCamp United States	13	979	700	511	376	268	20	1.4k
Theresa Flynn United States	12	1.1k 1.1×	807 1.2×	509 1.0×	412 1.1×	196 0.7×	15	1.6k
Denis Henrard United States	19	882 0.9×	413 0.6×	735 1.4×	364 1.0×	167 0.6×	28	1.4k
Wayne B. Dyer Australia	24	1.5k 1.6×	1.1k 1.6×	812 1.6×	493 1.3×	389 1.5×	52	2.3k
D C Shugars United States	12	1.1k 1.1×	401 0.6×	706 1.4×	365 1.0×	376 1.4×	13	1.5k
Leo Heyndríckx Belgium	24	1.1k 1.1×	365 0.5×	938 1.8×	278 0.7×	236 0.9×	63	1.5k
J J de Jong Netherlands	12	1.3k 1.3×	402 0.6×	887 1.7×	250 0.7×	232 0.9×	15	1.4k
Steve McAdam United Kingdom	16	1.1k 1.1×	1.3k 1.8×	367 0.7×	512 1.4×	271 1.0×	23	2.0k
Justin Pollara United States	20	738 0.8×	773 1.1×	386 0.8×	466 1.2×	268 1.0×	58	1.5k
Susan Allen United States	11	1.8k 1.8×	745 1.1×	1.1k 2.2×	460 1.2×	361 1.3×	16	2.0k
Åsa Björndal Sweden	16	1.9k 2.0×	940 1.3×	1.2k 2.3×	336 0.9×	383 1.4×	24	2.2k

Countries citing papers authored by Allan C. deCamp

Since Specialization

Citations

This map shows the geographic impact of Allan C. deCamp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allan C. deCamp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allan C. deCamp more than expected).

Fields of papers citing papers by Allan C. deCamp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allan C. deCamp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allan C. deCamp. The network helps show where Allan C. deCamp may publish in the future.

Co-authorship network of co-authors of Allan C. deCamp

This figure shows the co-authorship network connecting the top 25 collaborators of Allan C. deCamp. A scholar is included among the top collaborators of Allan C. deCamp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Allan C. deCamp. Allan C. deCamp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shen, Xiaoying, Bette Korber, Rachel L. Spreng, et al.. (2025). A Pentavalent HIV-1 Subtype C Vaccine Containing Computationally Selected gp120 Strains Improves the Breadth of V1V2 Region Responses. Vaccines. 13(2). 133–133. 2 indexed citations

Kalams, Spyros A., Barbara K. Felber, James I. Mullins, et al.. (2024). Focusing HIV-1 Gag T cell responses to highly conserved regions by DNA vaccination in HVTN 119. JCI Insight. 9(18). 3 indexed citations

Mayer, Bryan T., Allan C. deCamp, Yunda Huang, et al.. (2022). Optimizing clinical dosing of combination broadly neutralizing antibodies for HIV prevention. PLoS Computational Biology. 18(4). e1010003–e1010003. 7 indexed citations

Mielke, Dieter, Sherry Stanfield-Oakley, Bhavesh Borate, et al.. (2021). Selection of HIV Envelope Strains for Standardized Assessments of Vaccine-Elicited Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies. Journal of Virology. 96(2). e0164321–e0164321. 6 indexed citations

Lee, Benjamin, Dorothy M. Dickson, Allan C. deCamp, et al.. (2018). Histo–Blood Group Antigen Phenotype Determines Susceptibility to Genotype-Specific Rotavirus Infections and Impacts Measures of Rotavirus Vaccine Efficacy. The Journal of Infectious Diseases. 217(9). 1399–1407. 59 indexed citations

Shmelkov, Evgeny, Michael Goger, Allan C. deCamp, et al.. (2017). Peptide Targeted by Human Antibodies Associated with HIV Vaccine-Associated Protection Assumes a Dynamic α-Helical Structure. PLoS ONE. 12(1). e0170530–e0170530. 11 indexed citations

Fioré-Gartland, Andrew, et al.. (2017). SieveSifter: a web-based tool for visualizing the sieve analyses of HIV-1 vaccine efficacy trials. Bioinformatics. 33(15). 2386–2388. 3 indexed citations

Huang, Ying, Carlos A. DiazGranados, Holly Janes, et al.. (2016). Selection of HIV vaccine candidates for concurrent testing in an efficacy trial. Current Opinion in Virology. 17. 57–65. 7 indexed citations

Kong, Rui, Mark K. Louder, Kshitij Wagh, et al.. (2014). Improving Neutralization Potency and Breadth by Combining Broadly Reactive HIV-1 Antibodies Targeting Major Neutralization Epitopes. Journal of Virology. 89(5). 2659–2671. 94 indexed citations

10.

Scott, JoAnna M., Allan C. deCamp, Michal Juraska, Michael P. Fay, & Peter B. Gilbert. (2014). Finite-sample corrected generalized estimating equation of population average treatment effects in stepped wedge cluster randomized trials. Statistical Methods in Medical Research. 26(2). 583–597. 45 indexed citations

11.

deCamp, Allan C., Peter Hraber, Robert T. Bailer, et al.. (2013). Global Panel of HIV-1 Env Reference Strains for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies. Journal of Virology. 88(5). 2489–2507. 192 indexed citations

12.

Gorse, Geoffrey J., Mark J. Newman, Allan C. deCamp, et al.. (2012). DNA and Modified Vaccinia Virus Ankara Vaccines Encoding Multiple Cytotoxic and Helper T-Lymphocyte Epitopes of Human Immunodeficiency Virus Type 1 (HIV-1) Are Safe but Weakly Immunogenic in HIV-1-Uninfected, Vaccinia Virus-Naive Adults. Clinical and Vaccine Immunology. 19(5). 649–658. 18 indexed citations

13.

Janes, Holly, Nicole Frahm, Allan C. deCamp, et al.. (2012). MRKAd5 HIV-1 Gag/Pol/Nef Vaccine-Induced T-Cell Responses Inadequately Predict Distance of Breakthrough HIV-1 Sequences to the Vaccine or Viral Load. PLoS ONE. 7(8). e43396–e43396. 20 indexed citations

14.

Frahm, Nicole, Allan C. deCamp, Donald K. Carter, et al.. (2011). Human adenovirus-specific T cells modulate HIV-specific T cell responses to an Ad5-vectored HIV-1 vaccine. Journal of Clinical Investigation. 122(1). 359–367. 110 indexed citations

15.

Rosa, Stephen C. De, Evan P. Thomas, John Bui, et al.. (2011). HIV-DNA Priming Alters T Cell Responses to HIV-Adenovirus Vaccine Even When Responses to DNA Are Undetectable. The Journal of Immunology. 187(6). 3391–3401. 40 indexed citations

16.

Gilbert, Peter B., Maggie Haitian Wang, Terri Wrin, et al.. (2010). Magnitude and Breadth of a Nonprotective Neutralizing Antibody Response in an Efficacy Trial of a Candidate HIV‐1 gp120 Vaccine. The Journal of Infectious Diseases. 202(4). 595–605. 90 indexed citations

17.

Stacey, Andrea, Philip J. Norris, Qin Li, et al.. (2009). Induction of a Striking Systemic Cytokine Cascade prior to Peak Viremia in Acute Human Immunodeficiency Virus Type 1 Infection, in Contrast to More Modest and Delayed Responses in Acute Hepatitis B and C Virus Infections. Journal of Virology. 83(8). 3719–3733. 555 indexed citations breakdown →

18.

Gray, Elin S., Diane Wycuff, Penny L. Moore, et al.. (2009). Antibody Specificities Associated with Neutralization Breadth in Plasma from Human Immunodeficiency Virus Type 1 Subtype C-Infected Blood Donors. Journal of Virology. 83(17). 8925–8937. 134 indexed citations

19.

Jin, Xia, Mark J. Newman, Stephen C. DeRosa, et al.. (2009). A novel HIV T helper epitope-based vaccine elicits cytokine-secreting HIV-specific CD4+ T cells in a Phase I clinical trial in HIV-uninfected adults. Vaccine. 27(50). 7080–7086. 34 indexed citations

20.

Jones, Norman G., et al.. (2008). AIDSVAX immunization induces HIV-specific CD8+ T-cell responses in high-risk, HIV-negative volunteers who subsequently acquire HIV infection. Vaccine. 27(7). 1136–1140. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact